MedTech Spectrum

Article Name North America

Balt’s Squid Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

The approval comes following the results from The Squid Trial for the Embolisation of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma study

06th February, 2026

His Choice Health Launches Unified Men’s Health Brand after 10,000+ Vasectomy Procedures

Physician-Led, Cash-Pay Platform Combines Two High-Volume Practices to Expand Access to Evidence-Based Men’s Health Care

06th February, 2026

Amsino International Signs Three-Year Supply Partnership with Partners Cooperative

The partnership ensures consistent product availability and enhances supply reliability for Partners members amidst ongoing supply-chain challenges across the healthcare industry

04th February, 2026

Belmont Medical Technologies Appoints Brian Larkin as Chief Executive Officer

Larkin joins Belmont with over three decades of leadership across medical technology and patient care sectors

04th February, 2026

Quanterix Announces FDA Submission for Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection

Submission utilises the comprehensive five-analyte panel and algorithm that formed the basis for Quanterix’s LucentAD Complete LDT

04th February, 2026

ATLAS Meditech Introduces Patient-Specific Virtual Brain Twins to Enhance Precision and Safety in Brain Surgery

ATLAS Simulation and ATLAS Surgeon enable neurosurgeons to rehearse complex brain procedures using ultra-realistic, AI-enhanced virtual twins tailored to each patient's anatomy

03rd February, 2026

Dandy Redefines Chairside Experience with Launch of Dandy Cart All-in-One Workstation

Available at no additional cost, Dandy Cart turns scans into clear, visual stories, driving stronger case acceptance

03rd February, 2026

Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients

These office-based procedures allow patients to receive treatment and return home the same day

03rd February, 2026

Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent

The IND clearance enables Trace to initiate first-in-human clinical studies evaluating the safety and intraoperative performance of LGW16-03 in surgical settings

02nd February, 2026

Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology

Vystar plans to apply Fluid Energy Conversion (FEC) technology to increase pathogen killing efficiency, reduce the size and cost of Vystar’s RxAir air purifiers

30th January, 2026

Olympus Announces U.S. Launch of the SecureFlex Single-Use Fine Needle Biopsy Device

Olympus' newest needle for endoscopic ultrasound-guided biopsy is designed to offer precision sampling when access matters most

29th January, 2026

Biocomposites launches SYNICEM spacers in Canada

Ready-to-use preformed antibiotic-loaded spacers for hip, knee and shoulder revisions

29th January, 2026

Preat Corporation Launches PreatLoc Overdenture Attachment System

An overdenture attachment system providing compatibility, reliability and precise performance

28th January, 2026

Patterson Veterinary Relaunches Refreshed NaVetor Veterinary Cloud Software after Acquiring Full Rights

Reinforces long-term commitment to innovative software with flexible options for growing practices

28th January, 2026

Spinal Resources Strengthens IP Portfolio with New Bezier Rod Patent

The patent's focus on a constant-slope transition ensures a gradual and predictable stiffness profile

23rd January, 2026

Reimagining Inpatient Mental Health Care for Long-Term Stability

The Primary Mental Health program aimed at providing earlier, sustained and integrated care for individuals before crises escalate into emergencies

22nd January, 2026

Machina Medical Receives FDA Clearance for MFUSE External Bleeding Control Device

MFUSE is designed to support clinicians in managing external bleeding by forming a flexible hydrogel barrier when applied to the wound site

21st January, 2026

Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Centre PH-ILD Study

Polarean is working in collaboration with VIDA Diagnostics (VIDA), providing centralised imaging operations, site orchestration, and advanced Xenon MRI biomarker analysis

21st January, 2026